Ji Xiaolong's resume.
1978 graduated from the third military medical university. 198 1 year. 65438-0987 did postdoctoral research in Anderson Cancer Center for one year. 1994 studied at Prince of Wales Hospital in Hong Kong. 1997 Visiting Professor, Washington State University. He has profound attainments in the early diagnosis of tumor and lymphoma, and solves more than 0/000 cases of difficult and key diagnosis in pathological consultation every year. 198l, the mechanism of tumor immune blocking was studied for the first time in China. 199 1 reported the first case of paragonimiasis in lymph nodes at home and abroad. 1996 found and reported a special type of Hodgkin's disease. 1997 first reported the mechanism of cancer cell death in the treatment of liver cancer. In July 2003, the first International Institute of Nanomedicine was established and served as its director. The newly developed "tumor autologous blood activation therapy" and "tumor morphology and mechanism research" for biotherapy of advanced cancer patients are rarely involved at home and abroad. He published more than 200 academic papers, participated in the compilation of monograph 12, and won 2 second prizes, 5 third prizes and 6 fourth prizes for military scientific and technological progress.